Patentability and predictability in AI-assisted drug discovery

Akin Gump Strauss Hauer & Feld LLP

Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery. The AlphaFold2 system developed by Google’s Deepmind was able to predict the 3D structures of over 200 million proteins - with accuracy on par with experimental methods - in just two years. AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process.

*Reprinted with permission. February 21, 2024

Please see full publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Akin Gump Strauss Hauer & Feld LLP

Akin Gump Strauss Hauer & Feld LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide